NCT01563055 2015-08-10A Phase I/II, Open-label Study of Ofatumumab Added to Chlorambucil in Previously Untreated Japanese Patients With Chronic Lymphocytic LeukemiaGlaxoSmithKlinePhase 2 Completed10 enrolled 52 charts